Phase 2 HR Positive Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Neoadjuvant Therapy Combined With Trastuzumab Rezetecan and Toripalimab for HR+/HER2-low Breast Cancer (NEOTORCH-BREAST 08)
HR Positive/HER2 Low Breast Cancer
First Affiliated Hospital of Zhejiang University111 enrolled5 locationsNCT07383818
Recruiting
Phase 2
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer
HR Positive HER2 Negative Advanced Breast Cancer
wanghaibo120 enrolled2 locationsNCT07285382
Recruiting
Phase 1Phase 2
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors
HR Positive HER2 Negative Advanced Breast Cancer
TYK Medicines, Inc180 enrolled2 locationsNCT06950086
Recruiting
Phase 2
SHR-A1811 Alone or in Combination With Adebrelimab as Neoadjuvant Treatment in HR Positive/HER2 Low Breast Cancer
HR Positive/HER2 Low Breast Cancer
Shengjing Hospital93 enrolled1 locationNCT06340230